For example, the administration of anti-inflammatory agents such as tumor necrosis factor-alpha (TNFα) inhibitors [6], minocycline, and FasL-Fas signaling inhibitors [7] led to lower immune cell infiltration and reduced axonal degeneration and RGC death in rodent models of glaucoma [8]. This evidence concerns the gene TNF and glaucoma.